GB201308658D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB201308658D0
GB201308658D0 GB201308658A GB201308658A GB201308658D0 GB 201308658 D0 GB201308658 D0 GB 201308658D0 GB 201308658 A GB201308658 A GB 201308658A GB 201308658 A GB201308658 A GB 201308658A GB 201308658 D0 GB201308658 D0 GB 201308658D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201308658A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GB201308658A priority Critical patent/GB201308658D0/en
Publication of GB201308658D0 publication Critical patent/GB201308658D0/en
Priority to PCT/GB2014/051469 priority patent/WO2014184545A2/en
Ceased legal-status Critical Current

Links

GB201308658A 2013-05-14 2013-05-14 Antibodies Ceased GB201308658D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201308658A GB201308658D0 (en) 2013-05-14 2013-05-14 Antibodies
PCT/GB2014/051469 WO2014184545A2 (en) 2013-05-14 2014-05-14 Antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201308658A GB201308658D0 (en) 2013-05-14 2013-05-14 Antibodies

Publications (1)

Publication Number Publication Date
GB201308658D0 true GB201308658D0 (en) 2013-06-26

Family

ID=48700766

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201308658A Ceased GB201308658D0 (en) 2013-05-14 2013-05-14 Antibodies

Country Status (2)

Country Link
GB (1) GB201308658D0 (en)
WO (1) WO2014184545A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110938063A (en) * 2018-09-21 2020-03-31 东进世美肯株式会社 Novel compound for capping layer and organic light emitting device including the same

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2971732A1 (en) 2014-12-23 2016-06-30 Bristol-Myers Squibb Company Antibodies to tigit
EA201890162A1 (en) 2015-06-29 2018-07-31 Бристол-Маерс Сквибб Компани ANTIBODIES TO CD40 WITH ENHANCED AGONISTIC ACTIVITY
MX2018010672A (en) 2016-03-04 2019-05-27 Univ Rockefeller Antibodies to cd40 with enhanced agonist activity.
CN113480655B (en) * 2017-03-28 2022-05-31 礼进生物医药科技（上海）有限公司 Therapeutic agents and methods for enhancing immune response in tumor microenvironment
TWI788340B (en) 2017-04-07 2023-01-01 美商必治妥美雅史谷比公司 Anti-icos agonist antibodies and uses thereof
EP3630831B1 (en) 2017-05-25 2022-06-15 Bristol-Myers Squibb Company Antagonistic cd40 monoclonal antibodies and uses thereof
WO2019133747A1 (en) 2017-12-27 2019-07-04 Bristol-Myers Squibb Company Anti-cd40 antibodies and uses thereof
CN110151987B (en) * 2018-02-11 2023-10-13 汕头大学医学院 Application of symmetrical IgG and composition thereof in preparation of medicines for treating and preventing tumors
AR117091A1 (en) 2018-11-19 2021-07-07 Bristol Myers Squibb Co MONOCLONAL ANTIBODIES ANTAGONISTS AGAINST CD40 AND THEIR USES
CN113728008B (en) 2019-04-10 2024-04-09 南开大学 anti-CD 40 antibodies and uses thereof
CN115666751A (en) * 2020-03-05 2023-01-31 动量制药公司 Method for producing highly sialylated immunoglobulins
US20230192867A1 (en) 2020-05-15 2023-06-22 Bristol-Myers Squibb Company Antibodies to garp
WO2022093857A1 (en) * 2020-10-26 2022-05-05 City Of Hope Oncolytic virus compositions and methods for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP2278020A3 (en) * 2002-04-09 2011-05-11 Nationwide Children's Hospital, Inc. Antibody gene transfer and recombinant AAV therefor
AU2005272993B2 (en) * 2004-07-15 2010-02-11 Xencor, Inc Optimized Fc variants
US20070023129A1 (en) 2005-07-29 2007-02-01 Stieler David C Method of coupling polymeric tubing to polymeric coated metal tubing
ES2589852T3 (en) * 2008-09-17 2016-11-16 Xencor Inc. IgE specific antibody
KR20140028013A (en) * 2011-05-25 2014-03-07 머크 샤프 앤드 돔 코포레이션 Method for preparing fc-containing polypeptides having improved properties

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110938063A (en) * 2018-09-21 2020-03-31 东进世美肯株式会社 Novel compound for capping layer and organic light emitting device including the same

Also Published As

Publication number Publication date
WO2014184545A3 (en) 2015-02-19
WO2014184545A2 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
IL269528A (en) Anti-fcrh5 antibodies
HRP20190502T1 (en) Afucosylated anti-fgfr2iiib antibodies
HK1217023A1 (en) Novel antibodies
GB201322583D0 (en) Antibodies
HK1220142A1 (en) Antibodies
GB201308658D0 (en) Antibodies
GB201315486D0 (en) Antibodies
GB201300706D0 (en) Antibody
IL245488A0 (en) Anti-ccl17 antibodies
GB201312226D0 (en) Improved antibodies
HK1220763A1 (en) Augurin immunoassay augurin
GB201318283D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)